Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Lung Cancer Update
Dr. Neil Love
Let's Go Devils Podcast
Primetime Radio Network
Glenn Diesen - Greater Eurasia Podcast
Glenn Diesen
Chương trình 60'
RFI Tiếng Việt
Am I the Jerk?
youtube.com/amithejerk
Am I the Jerk?
juliana luis
คืนเผาผี Ghost Night
Ghost Night
Era Uma Vez Um Podcast
Carol Camanho
The Mental Healness Podcast
Lee Hammock
Locked On MLB - Daily Podcast On Major League Baseball
Locked On Podcast Network, Paul Francis Sullivan
Mid-South Gardening Podcast
KWAM990
El Laboratorio de Juan
El Laboratorio de Juan
Daily Crypto News
Matt Diemer
NORMAL GAYS Podcast
NORMAL GAYS
YinkusPepe Talks
Yinkuspepe
艾灸养生108招 |病来了，不用怕
冯名雨艾灸
Didn't Get All Of It
Fatal Four Podcasts
Gardening Simplified
Newsradio WOOD 1300 and 106.9 FM (WOOD-AM)
Locked On Golden Knights - Daily Podcast On the Vegas Golden Knights
Tony Cordasco, Locked On Podcast Network, chris gawlik
Coffee Moaning
Mark Adderley
Classic Rocktails
classicrocktails
Washington Commanders News Today | 2 Min News | The Daily News Now!
The Daily News Now!
Олег Жданов, Украинский военный эксперт
Олег Жданов
Community Radio Kilkenny Sport
CRKC Sport
The West Ham Way
Mark Carlaw
Reuters World News
Reuters
Reuters World News
Stephani Schupbach
Liberty and Prosperity
Seth Grossman
Podcast – Liberty and Prosperity
Seth Grossman
Comentaristas
CBN
Smerconish on CNN
CNN Podcasts
EsTImate
Jeymi Febles
Diabetic Foot Files
Diabetic Foot Files
TMZ's Inside The Ring
TMZ
The ArsenalVision Podcast - Arsenal FC
ArsenalVision Podcast LLC
DK Pittsburgh Sports: Daily podcasts on Steelers, Penguins, Pirates!
Dejan Kovacevic
Scout's Eye with Matt Williamson
Bleav, Dejan Kovacevic, Matt Williamson
Todo
Dr. Neil Love
Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:Introduction (0:00)Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:...
Featuring an interview with Prof Martin Reck, including the following topics:Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunothera...
Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding ...
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported...
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications...
Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCL...
Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy ...
Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.CME information and select publications here.
Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and se...
Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publ...
Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publi...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publicati...
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for pat...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and s...
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies fo...
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as e...
Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage t...
Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual m...
Dr Jessica J Lin from Massachusetts General Hospital in Boston and Dr Joel W Neal from Stanford Cancer Institute in California summarize major treatment advances over the past year and review relevant ongoing clinical tr...
Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. CME information and select publications here.
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.